Biden Administration Unveils First Drugs for Medicare Price Negotiations - The New York Times

Medicare gained the authority to negotiate the price of some prescription medicines when Congress passed the Inflation Reduction Act last year, a signature legislative achievement for Mr. Biden. The announcement on Tuesday is a key step toward those negotiations, which will unfold over the coming months, with the new prices taking effect in 2026… 

Six pharmaceutical manufacturers — Astellas Pharma, AstraZeneca, Boehringer Ingelheim, Bristol Myers Squibb, Johnson & Johnson and Merck — have taken the Biden administration to court in an attempt to block the negotiation program. The industry's main trade group and the U.S. Chamber of Commerce have also filed suit…

https://www.nytimes.com/2023/08/29/us/politics/medicare-drug-pricing-negotiations.html